Monika Madai

Pecs, BA 7624, Hungary

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Fusion Inhibition of Zika Virus Entry by a Teicoplanin Pseudoaglycone Derivative with Broad Antiviral Activity.

Fusion Inhibition of Zika Virus Entry by a Teicoplanin Pseudoaglycone Derivative with Broad Antiviral Activity.

Journal: Pharmaceutics

Published: June 04, 2026

The Redesign of the Molecular Scaffold of Viral Ion Channel Blockers.

The Redesign of the Molecular Scaffold of Viral Ion Channel Blockers.

Journal: Computational and structural biotechnology journal

Published: May 18, 2026

Surveillance of Shrew-Borne Hantaviruses Expands Viral Host Range in Hungary.

Surveillance of Shrew-Borne Hantaviruses Expands Viral Host Range in Hungary.

Journal: Animals : an open access journal from MDPI

Published: November 14, 2025

Sindbis Virus-Host Interactions in Human Neuroblastoma Cells: Implications for Viral Pathogenesis and Replication.

Sindbis Virus-Host Interactions in Human Neuroblastoma Cells: Implications for Viral Pathogenesis and Replication.

Journal: Viruses

Published: September 11, 2025

Evaluating the Protective Role of Intranasally Administered Avian-Derived IgY Against SARS-CoV-2 in Syrian Hamster Models.

Evaluating the Protective Role of Intranasally Administered Avian-Derived IgY Against SARS-CoV-2 in Syrian Hamster Models.

Journal: Vaccines

Published: October 09, 2024

The PARP inhibitor rucaparib blocks SARS-CoV-2 virus binding to cells and the immune reaction in models of COVID-19.

The PARP inhibitor rucaparib blocks SARS-CoV-2 virus binding to cells and the immune reaction in models of COVID-19.

Journal: British journal of pharmacology

Published: September 15, 2023

Author Correction: Isolation of infectious Lloviu virus from Schreiber's bats in Hungary.

Author Correction: Isolation of infectious Lloviu virus from Schreiber's bats in Hungary.

Journal: Nature communications

Published: September 06, 2022

Single-particle detection of native SARS-CoV-2 virions by microfluidic resistive pulse sensing.

Single-particle detection of native SARS-CoV-2 virions by microfluidic resistive pulse sensing.

Journal: Colloids and surfaces. B, Biointerfaces

Published: March 24, 2022

The Anti-Histamine Azelastine, Identified by Computational Drug Repurposing, Inhibits Infection by Major Variants of SARS-CoV-2 in Cell Cultures and Reconstituted Human Nasal Tissue.

The Anti-Histamine Azelastine, Identified by Computational Drug Repurposing, Inhibits Infection by Major Variants of SARS-CoV-2 in Cell Cultures and Reconstituted Human Nasal Tissue.

Journal: Frontiers in pharmacology

Published: January 24, 2022

Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity.

Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity.

Journal: PLoS computational biology

Published: November 19, 2021

Natural Apocarotenoids and Their Synthetic Glycopeptide Conjugates Inhibit SARS-CoV-2 Replication.

Natural Apocarotenoids and Their Synthetic Glycopeptide Conjugates Inhibit SARS-CoV-2 Replication.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: October 01, 2021

Isolation of infectious Lloviu virus from Schreiber's bats in Hungary.

Isolation of infectious Lloviu virus from Schreiber's bats in Hungary.

Journal: Nature communications

Published: August 10, 2021

Showing 1-12 of 27

Last Updated: 09/26/2026